Brand Engagement Network, Inc.

What they do

BEN develops enterprise-grade conversational AI built on its proprietary Engagement Language Model (ELM), which is designed to operate in secure, closed-loop environments using organization-approved data. Its platform spans modules for perception, understanding and response, including natural language processing, multisensory awareness, sentiment and environmental analysis, and real-time personalization. The company has focused initial commercialization on healthcare, with expansion into hospitality, insurance, advertising and media. On June 30, 2026 it acquired Cataneo GmbH, whose MYDAS platform supports advertising sales, scheduling, traffic, content management, monetization and analytics for broadcasters and media organizations.

Revenue drivers

• AI engagement platform (healthcare and other verticals) — Historically minimal; revenue was $35,210 in 2023, $99,790 in 2024 and $275,120 in 2025. The company describes itself as pre-revenue with pilots not yet sold beyond the pilot stage.
• Cataneo GmbH media and advertising software — Acquired June 30, 2026; Cataneo generated more than $8.6 million of revenue in 2025. Its MYDAS platform manages more than 6 billion in annual advertising inventory across more than 1,000 media brands and 200-plus broadcast and digital channels.
• Healthcare joint ventures and international licensing — BEN formed a 50/50 joint venture, INTERVENT Health AI, with INTERVENT International on June 11, 2026, and its Skye Salud program in Mexico advanced to a next phase on June 23, 2026. Through Skye AI USA it holds a 25% common equity interest in Skye Africa Intelligence and a 35% recurring revenue share under an African licensing arrangement.

Recent performance

Second-quarter 2026 revenue was $56,562, down from $104,311 in the first quarter and $200,000 in the fourth quarter of 2025. The Cataneo acquisition closed on the final day of the quarter, so it contributed no operating revenue in the period; total assets rose from $15.3 million at December 31, 2025 to $30.7 million at June 30, 2026, driven primarily by approximately $10.8 million of goodwill and additional intangibles. Shareholders' equity increased to $19.4 million from $3.5 million at year-end 2025, and cash and cash equivalents rose to $708,202 from $172,000. Accounts payable fell by $1.8 million and short-term debt by nearly $1.0 million, with those items plus warrant liabilities down about $3.3 million. Full-year 2025 revenue was $275,120 with a net loss of $8.6 million.

Strategy

Management's stated focus is combining BEN's AI and intelligent engagement technology with Cataneo's media and monetization capabilities across a broader set of markets and customer relationships. The company continues to invest selectively in healthcare and emerging international markets, including the INTERVENT Health AI joint venture and the $1 million investment in Accelevate Solutions for approximately 10% ownership, with warrants that could raise ownership to about 20%. It also strengthened its balance sheet by repaying $640,332 of indebtedness, including $630,332 owed to Hana Bank, South Korea, and completing $596,005 of debt-to-equity conversions in the first half of 2026. BEN says it will require substantial additional capital to develop products and fund operations.

Risks

• Limited operating history and no meaningful product revenue — BEN states it is a development stage company and has not generated significant revenue to date, has not sold products beyond the pilot stage, and has a history of losses.
• Customer concentration — The company expects to be dependent on a limited number of customers and end markets, so losing or reducing revenue from any significant customer could materially hurt results.
• Need for substantial additional capital — BEN expects significant ongoing operating, research and development, and public-company costs and states it will require substantial additional capital to develop products and fund operations.
• Integration and dilution from the Cataneo acquisition — The June 30, 2026 acquisition added approximately $10.8 million of goodwill and intangibles and $4.3 million of stock consideration, and the company also notes that future resales of common stock may depress the market price.

Outlook

Management says the closing of Cataneo on the final day of the quarter is an important milestone and that, on a pro forma basis, Cataneo's contribution would have meaningfully increased BEN's revenue base for the first half of 2026. The stated focus now is bringing the combined capabilities together and continuing to innovate, while selectively investing in healthcare and international opportunities. The company cautions that it remains a development stage business requiring substantial additional capital.